Caprock Group’s Halozyme HALO Stock Holding History

Caprock Group’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6,990	Closed	-$299K	–	517
2020 Q4	$299K	Buy	+6,990	New	+$251K	0.03%	326
2020 Q3	–	Sell	-8,100	Closed	-$217K	–	435
2020 Q2	$217K	Buy	+8,100	New	+$183K	0.03%	348

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Caprock Group's HALO Position: Q1 2021 in Review

Caprock Group sold out of Halozyme (HALO) in Q1 2021, closing a stake of 6,990 shares — an estimated $299K sold.

Caprock Group first reported a position in HALO in Q2 2020 and held it in 2 quarters. The position peaked at $299K in Q4 2020. 336 funds tracked by Wall St. Rank hold HALO as of Q1 2021.

Caprock Group reported no remaining Halozyme position as of Q1 2021 after selling out during the quarter.
Caprock Group sold 6,990 Halozyme shares in Q1 2021, an estimated $299K.
Caprock Group first reported a position in Halozyme in Q2 2020 and held it in 2 quarters.
Caprock Group's Halozyme position peaked at $299K in Q4 2020.
336 funds tracked by Wall St. Rank held Halozyme as of Q1 2021.

Based on Caprock Group's 13F filing for Q1 2021, filed 29 Apr 2021.